Sean P Heffron
Overview
Explore the profile of Sean P Heffron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heffron S, ONeill K, Zhong J, Xia Y, McCarthy M
Am J Health Promot
. 2025 Feb;
:8901171251324018.
PMID: 40009867
Although healthcare workers may be aware of the risks of physical inactivity, their levels of physical activity (PA) are similar to those of all US adults, with less than half...
2.
Zahid S, Schlamp F, Gildea M, Lin B, Chaloemtoem A, Falis M, et al.
Arterioscler Thromb Vasc Biol
. 2025 Jan;
45(2):e48-e62.
PMID: 39744840
Background: Cholesterol efflux capacity (CEC) of HDL (high-density lipoprotein) is inversely associated with incident cardiovascular events, independent of HDL cholesterol. Obesity is characterized by low HDL cholesterol and impaired HDL...
3.
McCarthy M, ONeill K, Zhong J, Xia Y, Heffron S
J Occup Environ Med
. 2024 Dec;
67(2):e123-e126.
PMID: 39663962
Objectives: This study aimed to describe the implementation of a workplace health promotion to address low levels of physical activity (PA). Methods: Using the Exploration, Preparation, Implementation, Sustainment (EPIS) framework,...
4.
Vanegas S, Curado S, Gujral A, Valverde G, Parraga S, Aleman J, et al.
BMJ Open
. 2024 Aug;
14(8):e081201.
PMID: 39181563
Purpose: We developed a comprehensive sleeve gastrectomy (SG) weight loss study cohort and biorepository to uncover mechanisms, biomarkers and predictive factors of weight loss, weight maintenance and amelioration of obesity-related...
5.
Hosseini K, Soleimani H, Maleki S, Nasrollahizadeh A, Tayebi S, Nelson J, et al.
BMC Cardiovasc Disord
. 2024 Jul;
24(1):395.
PMID: 39080549
Background: High-intensity statin therapy is currently recommended initial guideline therapy in ACS treatment. However, only a minority of patients are achieving LDL-C attainment goal at 6 months. Proprotein convertase subtilisin/kexin...
6.
McGowan N, Zhong J, Trasande L, Hellmann J, Heffron S
Int J Clin Trials
. 2024 Apr;
11(1):53-60.
PMID: 38585621
Background: Low-dose aspirin is ineffective for primary prevention of cardiovascular events in people with body weight greater than 70kg. While the prevalent explanation for this is reduced platelet cyclooxygenase-1 (COX-1)...
7.
Stevenson M, Srivastava A, Nacher M, Hall C, Palaia T, Lee J, et al.
Obes Surg
. 2024 Jan;
34(3):928.
PMID: 38236349
No abstract available.
8.
Stevenson M, Srivastava A, Nacher M, Hall C, Palaia T, Lee J, et al.
Obes Surg
. 2024 Jan;
34(3):911-927.
PMID: 38191966
Purpose: Roux-en-Y gastric bypass (RYGB) leads to the improvement of many obesity-associated conditions. The degree to which post-operative macronutrient composition contributes to metabolic improvement after RYGB is understudied. Methods: A...
9.
Tarabanis C, Long C, Scolaro B, Heffron S
Nutr Metab Cardiovasc Dis
. 2023 Oct;
33(12):2326-2333.
PMID: 37788953
Aims: We reviewed the literature to date for high-level evidence on the cardiovascular and other health effects of olive oil with a focus on the amount, frequency of use and...
10.
Sidhu S, Aleman J, Heffron S
Arterioscler Thromb Vasc Biol
. 2023 Aug;
43(10):1764-1774.
PMID: 37650325
Cardiovascular disease risk is known to be influenced by both the severity of a risk factor and the duration of exposure (eg, LDL [low-density lipoprotein] cholesterol, tobacco smoke). However, this...